2025-12-03 - Analysis Report
Okay, here's a comprehensive analysis of Albemarle Corp (ALB) based on the provided data.

**1. Return Rate Comparison**

*   **Ticker:** ALB
*   **Company Overview:** Albemarle Corp is a global specialty chemicals company focused on lithium, bromine specialties, and catalysts.
*   **ALB Cumulative Return:** 24.72%
*   **S&P 500 (VOO) Cumulative Return:** 100.36%
*   **Divergence:** -76.5 (Relative Divergence: 14.2)

**Analysis:** ALB has significantly underperformed the S&P 500. The divergence of -76.5 indicates a substantial difference in cumulative returns. The relative divergence of 14.2 suggests that ALB's current performance, relative to its historical divergence range with the S&P 500, is near the lower end.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha  | Beta  | Cap(B) |
|------------|---------|-------|--------|-------|--------|
| 2015-2017  | 85.0%   | 68.0% | 56.0%  | 0.1   | 15.1   |
| 2016-2018  | 9.0%    | 68.0% | -6.0%  | 0.0   | 9.1    |
| 2017-2019  | -44.0%  | 73.9% | -66.0% | 0.1   | 8.6    |
| 2018-2020  | 44.0%   | 79.4% | 20.0%  | 0.2   | 17.4   |
| 2019-2021  | 149.0%  | 79.4% | 103.0% | -0.1  | 27.5   |
| 2020-2022  | 148.0%  | 79.9% | 149.0% | 0.5   | 25.5   |
| 2021-2023  | -26.0%  | 81.9% | -27.0% | 0.5   | 17.0   |
| 2022-2024  | -152.0% | 81.9% | -172.0%| 0.3   | 10.1   |
| 2023-2025  | -197.0% | 81.9% | -261.0%| -0.9  | 15.2   |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate shows significant volatility. Recent years (2022-2025 and 2023-2025) have seen massive negative growth.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant risk and price declines over the periods.
*   **Alpha:**  Alpha, which represents excess return compared to a benchmark, is strongly negative in the recent years, suggesting poor risk-adjusted performance.
*   **Beta:** Beta fluctuates. Recent years (2020-2023, 2021-2023, 2022-2024) show positive Beta indicating that the stock's price tends to move in the same direction as the market but with a slightly greater magnitude. The Beta of -0.9 for 2023-2025 indicates an inverse relationship with the market.
*   **Cap(B):** The market capitalization (in billions) also shows fluctuation, decreasing significantly in recent periods.

**2. Recent Stock Price Fluctuations**

*   **Close:** 129.41
*   **Last Market Data:** {'price': 129.415, 'previousClose': 128.33, 'change': 0.85}
*   **5-day SMA:** 125.49
*   **20-day SMA:** 112.10
*   **60-day SMA:** 96.12

**Analysis:**

The stock price is currently above all three Simple Moving Averages (SMA), which is generally a bullish signal. The 5-day SMA is closest to the current price, followed by the 20-day, and then the 60-day, indicating a potential uptrend. The recent price change of 0.85 suggests a continuing upward trend.

**3. Indicators Analysis**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 77.25 (Overbought)
*   **PPO:** 0.82
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 1.3 (+): Short-term rise
*   **Expected Return (%):** 118.1% (Long-term)

**Analysis:**

*   The MRI suggests a *High* Investment recommendation, despite the recent poor performance.
*   The RSI indicates that the stock is currently *overbought*, which could signal a potential pullback.
*   The Hybrid Signal is recommending purchasing the stock.
*   The positive change in relative divergence over the past 20 days confirms a short-term upward trend.
*   The very high expected return is a positive factor but should be considered in light of the high volatility and recent underperformance.

**4. Recent News & Significant Events**

*   **ALB: Risks Mount For Bulls (Seeking Alpha):** Suggests caution, indicating potential downsides despite recent gains.
*   **Albemarle (ALB) Receives Upgrade and Price Target Raise From Bai (GuruFocus):**  A positive signal, suggesting potential upside.
*   **Albemarle Corporation $ALB Shares Bought by Edgestream Partners L.P. (MarketBeat):** Positive, indicates institutional investor confidence.
*   **ALB December 2026 Options Begin Trading (Nasdaq):** Indicates market interest and liquidity.
*   **Albemarle Rallies 26% in a Month: Here's How to Play the Stock (Yahoo Finance):** Highlights recent positive price movement, but strategy required for investment.
*   **LAC vs. ALB: Which Lithium Stock Has More Upside Potential Now? (Zacks Investment Research):** Comparison with a competitor; consider the outcome.

**Analysis:**

The news is mixed. While some reports suggest positive momentum and upgrades, others highlight risks. The conflicting information warrants a cautious approach.

**4-2. Analyst Opinions**

*   **Consensus:** Hold (2.65)
*   **Target Price:** 106.49 (Average)

**Analysis:**

The analyst consensus is "Hold" with a low average target price of $106.49, much lower than the current price, which suggests the analysts believe the stock is overvalued. No information regarding recent rating changes.

**5. Recent Earnings Analysis**

| Date       | EPS    | Revenue    |
|------------|--------|------------|
| 2025-11-05 | -1.72  | 1.31 B$    |
| 2025-08-04 | -0.16  | 1.33 B$    |
| 2025-04-30 | 0      | 1.08 B$    |
| 2024-11-06 | -9.45  | 1.35 B$    |
| 2025-11-05 | -9.45  | 1.35 B$    |

**Analysis:**

Recent EPS figures are negative, indicating unprofitability. Revenue has been fluctuating. The negative EPS is a significant concern, despite relatively stable revenue.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $1.31B  | 8.99%         |
| 2025-06-30   | $1.33B  | 14.80%        |
| 2025-03-31   | $1.08B  | 14.51%        |
| 2024-12-31   | $1.23B  | 11.22%        |
| 2024-09-30   | $1.35B  | -7.68%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
|--------------|----------|----------|
| 2025-09-30   | $10.00B  | -1.61%   |
| 2025-06-30   | $10.24B  | 0.22%    |
| 2025-03-31   | $10.03B  | 0.41%    |
| 2024-12-31   | $9.96B   | 0.76%    |
| 2024-09-30   | $10.24B  | -10.44%  |

**Analysis:**

*   **Revenue:** Revenue has been somewhat consistent, although there has been a recent decrease.
*   **Profit Margin:** The profit margin has been fluctuating and was even negative in Q3 2024, which is a concerning sign.
*   **Equity:** Equity has remained relatively stable.
*   **ROE:** The Return on Equity (ROE) is primarily negative, indicating poor profitability in relation to shareholders' equity.

**7. Comprehensive Analysis (Summary)**

ALB has significantly underperformed the S&P 500, and its recent financial performance is concerning. Key points:

*   **Underperformance:**  Significant divergence from the S&P 500.
*   **Volatility:** High Maximum Drawdown and fluctuating CAGR indicate high price volatility.
*   **Profitability Issues:** Negative EPS and fluctuating/negative ROE.
*   **Analyst Sentiment:**  "Hold" rating with a lower target price than current level suggests analysts believe the stock may be overvalued.
*   **Technical Indicators:** Overbought RSI suggests a potential pullback.
*   **Mixed News:** Conflicting news reports warrant caution. Some upgrades and institutional buying, but also concerns about increasing risks.
*   **Market Risk Indicator Contradiction:** Despite the current financial performance, the MRI recommends a "High Investment," which seems incongruous.

**Overall Recommendation:**

Based on the comprehensive analysis, a **neutral to cautious** approach is recommended for ALB.

*   **Reasons for Caution:** Significant underperformance, high volatility, negative EPS, low ROE, conflicting news, and analyst concerns warrant caution.
*   **Potential Upsides:** The recent upward price movement and the MRI rating and Hybrid signal point to potential upside. The long-term expected return is very high, though it should be considered speculative.

**Recommendations:**

1.  **Thorough Due Diligence:** Conduct in-depth research into the company's financials, market position, and future prospects.
2.  **Monitor News and Events:** Stay informed about the latest news and developments related to Albemarle and the lithium industry.
3.  **Consider Risk Tolerance:**  Evaluate your risk tolerance and investment goals before investing in ALB, given its high volatility.
4.  **Potential Pullback Entry Point:** Consider waiting for a pullback from the overbought RSI levels before initiating a position.
5.  **Factor in Market Conditions:** The MRI should be interpreted with consideration to other indicators and news.

**Disclaimer:** This is an AI-generated analysis and is not financial advice. Consult with a qualified financial advisor before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.